Saving lives: long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy
Prospective randomised trials have demonstrated convincingly the benefits of drug treatment of hypertension. Treatment with conventional antihypertensive agents reduces the incidence of cardiovascular events by about that which would be expected from epidemiological data for the achieved difference...
Main Author: | Gordon T McInnes |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2000-06-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | http://jra.sagepub.com/content/1/2_suppl/S17.full.pdf |
Similar Items
-
Saving lives: Long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy
by: Gordon T McInnes
Published: (2000-06-01) -
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers
by: Neil Poulter, et al.
Published: (2006-06-01) -
Long-term use of angiotensin receptor blockers and the risk of cancer.
by: Laurent Azoulay, et al.
Published: (2012-01-01) -
Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
by: Hyun Woong Lee
Published: (2014-12-01) -
The Benefits of Angiotensin Receptor Blockers in Patients with Chronic Heart Failure and Multiple Co-morbidities
by: Erland Erdmann
Published: (2005-06-01)